181 related articles for article (PubMed ID: 37354026)
1. Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.
Sison SDM; Lin KJ; Najafzadeh M; Ko D; Patorno E; Bessette LG; Zakoul H; Kim DH
J Am Geriatr Soc; 2023 Oct; 71(10):3179-3188. PubMed ID: 37354026
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
3. Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.
Claxton JS; Chamberlain AM; Lutsey PL; Chen LY; MacLehose RF; Bengtson LGS; Alonso A
Am J Med; 2020 Oct; 133(10):e554-e567. PubMed ID: 32320695
[TBL] [Abstract][Full Text] [Related]
4. Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease.
Burrows NR; Koyama AK; Choudhury D; Yu W; Pavkov ME; Nee R; Cheung AK; Norris KC; Yan G
Am J Nephrol; 2022; 53(8-9):652-662. PubMed ID: 36209732
[TBL] [Abstract][Full Text] [Related]
5. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.
Braunstein JB; Anderson GF; Gerstenblith G; Weller W; Niefeld M; Herbert R; Wu AW
J Am Coll Cardiol; 2003 Oct; 42(7):1226-33. PubMed ID: 14522486
[TBL] [Abstract][Full Text] [Related]
6. The impact of diabetes and osteoarthritis on the occurrence of stroke, acute myocardial infarction, and heart failure among older adults with non-valvular atrial fibrillation in Hawaii: a retrospective observational cohort study.
Matsunaga M; Chen JJ; Jijiwa M; Lim E
BMC Public Health; 2021 Jun; 21(1):1183. PubMed ID: 34154554
[TBL] [Abstract][Full Text] [Related]
7. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease.
McClellan WM; Langston RD; Presley R
J Am Soc Nephrol; 2004 Jul; 15(7):1912-9. PubMed ID: 15213281
[TBL] [Abstract][Full Text] [Related]
8. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
[TBL] [Abstract][Full Text] [Related]
9. The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function.
Sullivan MK; Carrero JJ; Jani BD; Anderson C; McConnachie A; Hanlon P; Nitsch D; McAllister DA; Mair FS; Mark PB; Gasparini A
BMC Med; 2022 Nov; 20(1):420. PubMed ID: 36320059
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
[TBL] [Abstract][Full Text] [Related]
11. Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.
Hubbard D; Colantonio LD; Rosenson RS; Brown TM; Jackson EA; Huang L; Orroth KK; Reading S; Woodward M; Bittner V; Gutierrez OM; Safford MM; Farkouh ME; Muntner P
Cardiovasc Diabetol; 2021 Mar; 20(1):58. PubMed ID: 33648518
[TBL] [Abstract][Full Text] [Related]
12. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort.
Hall M; Dondo TB; Yan AT; Mamas MA; Timmis AD; Deanfield JE; Jernberg T; Hemingway H; Fox KAA; Gale CP
PLoS Med; 2018 Mar; 15(3):e1002501. PubMed ID: 29509764
[TBL] [Abstract][Full Text] [Related]
13. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
Tromp J; Tay WT; Ouwerkerk W; Teng TK; Yap J; MacDonald MR; Leineweber K; McMurray JJV; Zile MR; Anand IS; Richards AMR; Lam CSP;
PLoS Med; 2018 Mar; 15(3):e1002541. PubMed ID: 29584721
[TBL] [Abstract][Full Text] [Related]
14. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
Chao CT; Lee SY; Wang J; Chien KL; Hung KY
Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) study.
Corsonello A; Fabbietti P; Formiga F; Moreno-Gonzalez R; Tap L; Mattace-Raso F; Roller-Wirnsberger R; Wirnsberger G; Ärnlöv J; Carlsson AC; Weingart C; Freiberger E; Kostka T; Guligowska A; Gil P; Martinez SL; Melzer I; Yehoshua I; Lattanzio F;
BMC Geriatr; 2020 Oct; 20(Suppl 1):350. PubMed ID: 33008303
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study.
Folkerts K; Kelly AMB; Petruski-Ivleva N; Fried L; Blankenburg M; Gay A; Velentgas P; Kovesdy CP
Nephron; 2021; 145(4):342-352. PubMed ID: 33789294
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Newly Diagnosed Atrial Fibrillation After Acute Myocardial Infarction: A Study of 184,980 Medicare Patients.
Ayinde H; Riedle B; Ojo A; Abugroun A; Girotra S; Polgreen L
Cardiovasc Revasc Med; 2022 Nov; 44():37-43. PubMed ID: 35835653
[TBL] [Abstract][Full Text] [Related]
18. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
Kipp R; Askari M; Fan J; Field ME; Turakhia MP
JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
[TBL] [Abstract][Full Text] [Related]
19. Outcomes associated with comorbid atrial fibrillation and heart failure in Medicare beneficiaries with acute coronary syndrome.
Chen SY; Crivera C; Stokes M; Boulanger L; Schein J
BMC Health Serv Res; 2014 Feb; 14():80. PubMed ID: 24555428
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidity on mortality among older persons with advanced heart failure.
Ahluwalia SC; Gross CP; Chaudhry SI; Ning YM; Leo-Summers L; Van Ness PH; Fried TR
J Gen Intern Med; 2012 May; 27(5):513-9. PubMed ID: 22095572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
